Boltz joins a consortium building a large dataset for zero-shot antibody design
GabriCorso · x · 2026-07-22
The post says that, alongside strong models, high-quality datasets are the most important ingredient in AI4Science. It highlights a new consortium organized by @AAlphaBio, with Boltz joining GSK, Cradle, and Dyno to generate a large dataset for zero-shot antibody design.
Related event: Boltz Bio Joins AI Drug Discovery Data Consortium(4 posts)→
More from Companies & People
- Peter Sellis, Ex-Discord & Snapchat Exec, Joins X as Head of Product — Polymarket · 2026-10-27
- Anthropic IPO filing reveals $11.6B quarterly revenue, $750B+ compute commitments — TiernanRayTech · 2026-10-27
- Anthropic's S-1 complains about AI doom media narratives it helped spread, critic notes — DrTechlash · 2026-10-27
- Anthropic's S-1: safety and model welfare may force it to keep old Claude versions alive — DrTechlash · 2026-10-27
- LangChain SF meetup to compare decision model Jev vs LLM judges for agent evals — LangChain · 2026-10-27
- OpenAI to livestream 'next era of cyber defense' event on November 12 — imjustnewatai · 2026-10-27